학술논문
EVALUATION OF THE LIFETIME BENEFITS OF METFORMIN AND SGLT2 INHIBITORS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW AND TWO-STAGE META-ANALYSIS.
Document Type
Article
Source
Subject
*TYPE 2 diabetes
*SODIUM-glucose cotransporter 2 inhibitors
*PEOPLE with diabetes
*CARDIOVASCULAR diseases
*METFORMIN
*
*
*
*
Language
ISSN
0735-1097